Elizondo David R 4
4 · ATS MEDICAL INC · Filed Sep 30, 2009
Insider Transaction Report
Form 4
ATS MEDICAL INCATSI
Elizondo David R
VP-Research & Development
Transactions
- Sale
Common Stock
2009-09-30$2.72/sh−3,770$10,260→ 57,159.205 total - Exercise/Conversion
Common Stock
2009-09-29+10,000→ 60,409.179 total - Exercise/Conversion
Restricted Stock Units
2009-09-29−10,000→ 20,000 totalFrom: 2007-09-29Exp: 2011-09-29→ Common Stock (30,000 underlying)
Holdings
- 40,000
Restricted Stock Units
From: 2009-07-30Exp: 2013-07-30→ Common Stock (40,000 underlying) - 66,065
Restricted Stock Units
From: 2010-03-15Exp: 2014-03-05→ Common Stock (66,065 underlying) - 26,511
Restricted Stock Units
From: 2008-03-15Exp: 2012-03-15→ Common Stock (26,511 underlying) - 70,103
Restricted Stock Units
From: 2009-03-15Exp: 2013-03-15→ Common Stock (70,103 underlying)
Footnotes (6)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2009.
- [F2]Includes shares acquired under the Employee Stock Purchase Plan as of July 31, 2009.
- [F3]1 unit for 1 share of Common Stock.
- [F4]Vests in cumulative annual installments of 20% beginning the date shown.
- [F5]Represents last vesting date.
- [F6]Vests in 20% annual cumulative installments starting on the date shown; in the second year remaining vesting is subject to acceleration if certain performance criteria are met.